REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates ...

Siemens has unveiled its Questa One functional safety solution, setting a new standard in the verification and validation of ...